TMCnet News
QIAGEN N.V. to Report Second Quarter and First Half of 2017 ResultsVENLO, Netherlands, July 13, 2017 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of 2017 on Thursday, July 27, at approximately 22:00 Central European Time (CET) / 16:00 Eastern Time (EDT). A conference call is planned for Friday, July 28, at 15:00 CET / 9:00 EDT hosted by Peer M. Schatz, Chief Executive Officer, and Roland Sackers, Chief Financial Officer. Conference Call and Webcast Details The conference call will begin at 15:00 CET / 9:00 EDT on July 28, 2017. The webcast will be accessible at www.qiagen.com/de/about-us/investors/corporate-calendar. A conference call replay will be available through August 4, 2017, by dialing: Contact: [email protected] About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharma and biotech companies) and Academia (life sciences research). As of March 31, 2017, QIAGEN employed approximately 4,600 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.
View original content:http://www.prnewswire.com/news-releases/qiagen-nv-to-report-second-quarter-and-first-half-of-2017-results-300487699.html SOURCE QIAGEN |